Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 24 Oct 2019 for ALDER BIOPHARMACEUTICALS INC. Read the official filing
Filing timeline
BuySaleJames B. Bucher
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
James B. Bucher: trading record in brief
All filings by James B. Bucher on record concern Alder Biopharmaceuticals Inc. In total, 9 filings cover trades dated from 30 November 2017 to 22 October 2019.
Sales make up the whole of the open-market record (1 sale, €24k). The rest of the record consists of 7 share grants. In 2019 alone, the filings show no purchases and 1 sale.
Most recently, on 24 October 2019, the filings show a share grant in Alder Biopharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 13 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James B. Bucher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
15,619 shares0Common StockSEC:0001209191-19-053921:2
1,345 shares@ US$9.202.2% of flowCommon StockSEC:0001209191-19-053921:0
904 shares@ US$9.201.5% of flowCommon StockSEC:0001209191-19-053921:1
27,677 shares@ US$18.0088.1% of flowCommon StockSEC:0001209191-19-053921:3
7,810 shares0Common StockSEC:0001209191-19-026033:0
1,897 shares@ US$13.854.6% of flowCommon StockSEC:0001209191-19-026033:1
273 shares@ US$9.350.4% of flowCommon StockSEC:0001209191-19-008565:0
2,000 shares@ US$9.353.1% of flowCommon StockSEC:0001209191-18-060011:0
1,623 shares@ US$9.352.5% of flowCommon StockSEC:0001209191-17-066205:0
9 of 9 declarations
